Events
Digestive Diseases Week (DDW), May 2-5, Chicago, IL
• J. A. Syage, et al.: “Continuous Composite Scoring Histologic and Biomarker Indicators for Celiac Disease” (Talk)
• J. A. Sealey-Voyksner, et al.: “Correlation of Symptoms and Quality of Life in an Interventional Treatment Study for Celiac Disease” (Poster)
Tampere Celiac Disease Symposium 2025, September 10-12, 2025, Tampere, Finland
• J. A. Syage, D. A. Leffler, J. A. Silvester, J. R. Maxwell, J. A. Sealey-Voyksner, J. A. Murray: "A Renormalization-Based Composite Scoring Framework Integrating Histologic and Biomarker Indicators in Celiac Disease" (Talk)
• J. A. Sealey-Voyksner, V. Loskutov, J. A. Syage, "Tiredness as a Key Driver of Quality of Life in Celiac Disease: Correlation of Symptom Severity and Improvement" (Poster)
• J. A. Syage, L. F. Risnes, K. E. A. Lundin, L. M. Sollid, J. A. Sealey-Voyksner, "Integration of Histologic and Biomarker Indicators in Celiac Disease Using a Renormalization Composite Scoring Approach" (Poster)
International Symposium - Celiac Disease: On the Horizon, May 1-2, 2025, Columbia University, NY
• J. A. Syage: "Latiglutenase: What We've Learned and Next Steps" (Invited Talk)
• J. A. Sealey-Voyksner: "Gluten: What is too Much?"
San Diego CEO Summit on Life Sciences, Biocom California, November 7, 2024, San Diego, CA
• Jack Syage, "Panel on Acquisitions" (Invited Panel Member)
20th International Celiac Disease Symposium (ICDS), September 5-7, 2024, Sheffield, UK
• J. A. Syage, et al.: "A Composite Mucosal Scale for Celiac Disease Encompassing both Morphology and Inflammation" (Poster)
Digestive Diseases Week (DDW), May 18-22, 2024, Washington, DC
• J. A. Syage, et al.: "A Composite Mucosal Scale for Celiac Disease Encompassing both Morphology and Inflammation" (Poster)
• J. A. Sealey-Voyksner, et al.: "Dynamics of Serologic Change to Gluten in Celiac Disease Patients" (Poster)
Digestive Diseases Week (DDW), May 6-9, Chicago, IL
• Jack A. Syage, et al.: “A Composite Quantitative Histology Scale Based on Vh:Cd and IEL” (Poster)
• J. A. Sealey-Voyksner, et al.: “Measuring Gluten in a Clinical Trial Setting”(Poster)
International Symposium – Celiac Disease: On the Horizon, April 29-30, 2023, Columbia University, NY
• Jack A. Syage: “Update on Latiglutenase” (Invited Talk)
19th International Celiac Disease Symposium (ICDS), October 19-22, 2022, Sorrento, Italy
• J. A. Syage, “Enzyme Therapy” (Invited Talk and Panel Discussion)
• J. A. Sealey-Voyksner, et al.: “Gluten in Urine Measurements Validate Latiglutenase Mechanism of Action in CeliacShield Gluten Challenge Study” (Poster)
• J. A. Syage, et al. “Considerations for a Composite Quantitative Histology Scale Based on Vh:Cd and IEL” (Poster)
BIO International Convention, June 13-16, San Diego, CA
• Jack Syage, “Breakthrough Treatments for Celiac Disease” (Invited Presentation)
Digestive Diseases Week (DDW), May 21-24 San Diego, CA
• J.A. Murray (Mayo), J. A. Syage, et al.: “CeliacShieldTM Gluten Challenge Study – Latiglutenase Protects the Mucosa and Attenuates Symptoms of Celiac Disease” (Invited Lecture Presentation)
• J. A. Sealey-Voyksner, et al.: “Gluten in Urine Measurements Validate Latiglutenase Mechanism of Action in CeliacShield Gluten Challenge Study” (Poster of Distinction and Poster Tour)
Celiac Disease, Where are the Patients and the Therapies?, April 8-9, 2022, Columbia University, NY
• Jennifer Sealey-Voyksner: “CeliacShieldTM Gluten Challenge Study” (Invited Talk)
Life Sciences Summit 2021, Sponsored by the NIH, November 9-10, 2021
• Jack Syage, “Breakthrough Treatments for Celiac Disease,” (Invited Presentation)
United European Gastroenterology (UEG) Week Virtual 2021, October 3-5, 2021
• Jennifer Sealey-Voyksner, “CeliacShieldTM Gluten Challenge Study: Latiglutenase Protects the Mucosa and Attenuates Symptoms in Celiac Disease Patients” (Invited talk – UEG Research Prize 2021 Session)
Celiac Disease Foundation Patient Education & Advocacy Summit, March 4, 2021
• Jennifer Sealey-Voyksner, “Current State of Celiac Disease Diagnosis, Treatment, and Clinical Research” (Chair)
Tampere Celiac Disease Symposium 2020 – From Genomics to Personalized Health, September 18-19, 2020, Tampere University, Tampere, Finland
• J. A. Syage, et al.: “Latest Latiglutenase Clinical Trial Updates”
• J. Sealey-Voyksner, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients”
International Symposium – Celiac Disease, Now and the Future, March 6-7, 2020, Columbia University, NY
• Jack A. Syage: “Enzymes are Still in the Picture: the Case for Latiglutenase” (Invited Talk)
• Jennifer A. Sealey-Voyksner: “Gluten Detection in Food” (Invited Talk)
Celiac Disease Foundation Patient Advocacy Summit, February 27, 2020, Washington, CD
• Jack A. Syage: “Today and Tomorrow in Biopharmaceutical Research, Treatment and Cure” (Panel Talk)